|
No records
|
|
275 |
6507688750 |
Elisna Syahruddin |
dr. Elisna Syahruddin, Ph.D., Sp.P(K) |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Cost-effectiveness analysis of tyrosine kinase inhibitors (erlotinib vs. gefitinib vs. afatinib) in non-small-cell lung cancer |
Nurhayati F., Anggriani Y., Syahruddin E., Ramadaniati H.U., Kusumaeni T. |
Journal of Applied Pharmaceutical Science |
|
Q2 |
|
|
|
225 |
15754578700 |
Menaldi Rasmin |
Prof. dr. H. Menaldi Rasmin, Sp.P(K), FCCP |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
In-hospital mortality of pulmonary tuberculosis with acute respiratory failure and related clinical risk factors |
Elhidsi M., Rasmin M., Prasenohadi |
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
|
Q3 |
|
|
|
260 |
15754578700 |
Menaldi Rasmin |
Prof. dr. H. Menaldi Rasmin, Sp.P(K), FCCP |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report |
Syam A.F., Pitoyo C.W., Suhendro S., Zulkarnain B., Indrasari N.D., Aditianingsih D., Irawan C., Susilo A., Rumende C.M., Wijaya I.P., Ibrahim F., Rasmin M., Alwi I., Makmun D. |
Acta medica Indonesiana |
|
Q3 |
|
|
|
55 |
36058523500 |
Triya Damayanti |
dr. Triya Damayanti, Sp.P., Ph.D. |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial |
Dilogo I.H., Aditianingsih D., Sugiarto A., Burhan E., Damayanti T., Sitompul P.A., Mariana N., Antarianto R.D., Liem I.K., Kispa T., Mujadid F., Novialdi N., Luviah E., Kurniawati T., Lubis A.M.T., Rahmatika D. |
Stem Cells Translational Medicine |
1 |
Q1 |
|
|
|
55 |
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial |
Dilogo I.H., Aditianingsih D., Sugiarto A., Burhan E., Damayanti T., Sitompul P.A., Mariana N., Antarianto R.D., Liem I.K., Kispa T., Mujadid F., Novialdi N., Luviah E., Kurniawati T., Lubis A.M.T., Rahmatika D. |
Stem Cells Translational Medicine |
1 |
Q1 |
|
|
|
68 |
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Integration of symptomatic, demographical and diet-related comorbidities data with SARS-CoV-2 antibody rapid diagnostic tests during epidemiological surveillance: A cross-sectional study in Jakarta, Indonesia |
Agustina R., Syam A.F., Wirawan F., Widyahening I.S., Rahyussalim A.J., Yusra Y., Rianda D., Burhan E., Salama N., Daulay R., Halim A.R.V., Shankar A.H. |
BMJ Open |
|
Q1 |
|
|
|
269 |
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Performance of ldbio aspergillus wb and ict antibody detection in chronic pulmonary aspergillosis |
Rozaliyani A., Setianingrum F., Azahra S., Abdullah A., Fatril A.E., Rosianawati H., Burhan E., Handayani D., Arifin A.R., Zaini J., Tugiran M., Adawiyah R., Syam R., Wibowo H., Wahyuningsih R., Kosmidis C., Denning D.W. |
Journal of Fungi |
|
Q1 |
|
|
|
281 |
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study |
Surendra H., Elyazar I.R., Djaafara B.A., Ekawati L.L., Saraswati K., Adrian V., Widyastuti, Oktavia D., Salama N., Lina R.N., Andrianto A., Lestari K.D., Burhan E., Shankar A.H., Thwaites G., Baird J.K., Hamers R.L. |
The Lancet Regional Health - Western Pacific |
2 |
#N/A |
|
|
|
347 |
36058554600 |
Erlina Burhan |
Dr. dr. Erlina Burhan, MSc, Sp.P |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
A living WHO guideline on drugs to prevent covid-19 |
Lamontagne F., Agoritsas T., Siemieniuk R., Rochwerg B., Bartoszko J., Askie L., MacDonald H., Amin W., Bausch F.J., Burhan E., Cecconi M., Chanda D., Dat V.Q., Du B., Geduld H., Gee P., Nerina H., Hashimi M., Hunt B.J., Kabra S., Kanda S., Kawano-Dourado L., Kim Y.-J., Kissoon N., Kwizera A., Leo Y.-S., Mahaka I., Manai H., Mino G., Nsutebu E., Pshenichnaya N., Qadir N., Ranganathan S.S., Sabzwari S., Sarin R., Sharland M., Shen Y., Souza J.P., Stegemann M., Ugarte S., Venkatapuram S., Vuyiseka D., Preller J., Brignardello-Petersen R., Kum E., Qasim A., Zeraatkar D., Owen A., Guyatt G., Lytvyn L., Diaz J., Vandvik P.O., Jacobs M. |
The BMJ |
17 |
Q1 |
|
|
|
304 |
36489441300 |
Fathiyah Isbaniah |
dr. Fathiyah Isbaniah, M.Pd.Ked., Sp.P(K). |
Departemen Pulmonologi dan Ilmu Kedokteran Respirasi |
Ilmu Penyakit Paru (Sp-1) |
Lung fibrosis sequelae after recovery from COVID-19 infection |
Susanto A.D., Triyoga P.A., Isbaniah F., Fairuz A., Cendikiawan H., Zaron F., Aryanti I., Irbah S.N., Hidayat M. |
Journal of Infection in Developing Countries |
1 |
Q3 |
|
|
